Bone morphogenetic protein 4 regulates microRNAs miR-494 and miR-126–5p in control of endothelial cell function in angiogenesis

Thrombosis and Haemostasis - Tập 117 Số 04 - Trang 734-749 - 2017
Jennifer Heinke1, Erika Saretzki, Franziska Pankratz, Bianca Engert, Sebastian Grundmann, Christoph Bode, Martin Moser, Qian Zhou
1Jennifer Susanne Esser, PhD, University Heart Center Freiburg, Department of Cardiology and Angiology I, Cardiovascular Biology Group, Breisacher Str. 33, 79106 Freiburg, Germany, Tel.: +49 76127070440, Fax: +49 76127070450, E-mail: [email protected].

Tóm tắt

SummaryMicroRNAs are small non-coding RNAs that negatively regulate posttranscriptional gene expression. Several microRNAs have been described to regulate the process of angiogenesis. Previously, we have shown that bone morphogenetic protein 4 (BMP4) increased the proangiogenic activity of endothelial cells. In this project, we now investigated how the pro-angiogenic BMP4 effect is mediated by microRNAs. First, we performed a microRNA array with BMP4-stimulated human umbilical vein endothelial cells (HUVECs). Among the topregulated microRNAs, we detected a decreased expression of miR-494 and increased expression of miR-126–5p. Next, we analysed the canonical Smad and alternative signalling pathways, through which BMP4 would regulate miR-126–5p and miR-494 expression. Furthermore, the functional effect of miR-494 and miR-126–5p on endothelial cells was investigated. MicroRNA-494 overexpression decreased endothelial cell proliferation, migration and sprout formation. Consistently, miR-494 inhibition increased endothelial cell function. As potential miR-494 targets, bFGF and BMP endothelial cell precursorderived regulator (BMPER) were identified and confirmed by western blot. Luciferase assays showed direct miR-494 binding in BMPER 3’UTR. In contrast, miR-126–5p overexpression increased pro-angiogenic endothelial cell behaviour and, accordingly, miR-126–5p inhibition decreased endothelial cell function. As a direct miR-126–5p target we identified the anti-angiogenic thrombospondin-1 which was confirmed by western blot analysis and luciferase assays. In the Matrigel plug assay application of antagomiR-494 increased endothelial cell ingrowth, whereas antagomiR-126–5p treatment decreased cell ingrowth in vivo. Taken together, through differential regulation of the anti-angiomiR-494 and the angiomiR-126–5p by BMP4 both microRNAs contribute to the pro-angiogenic BMP4 effect on endothelial cells.Supplementary Material to this article is available online at www.thrombosis-online.com.

Từ khóa


Tài liệu tham khảo

10.1161/01.RES.0000255691.76142.4a

10.1016/j.cell.2011.08.039

10.1038/nrd2792

10.1016/j.cytogfr.2005.01.004

10.1007/s12079-009-0060-8

Landskroner-Eiger, 2013, Cold Spring Harbor Persp Med, 3, a006643

10.1016/j.gde.2009.04.002

10.1016/S0092-8674(04)00045-5

10.1161/CIRCRESAHA.107.153916

10.1161/01.RES.0000265065.26744.17

10.1074/jbc.M413394200

10.1016/j.devcel.2008.07.008

10.1016/j.devcel.2008.07.002

10.1097/MOH.0000000000000040

10.1038/ncb2441

10.1182/blood-2012-01-407106

10.1038/nrm2297

10.1016/j.cytogfr.2015.12.005

10.1016/j.cytogfr.2009.05.001

10.1038/cr.2008.326

10.1016/j.devcel.2012.01.007

10.1186/1471-2121-10-20

10.2217/bmm.11.81

Hata, 2015, Intern J Mol Med, 35, 563, 10.3892/ijmm.2015.2060

10.1016/j.molcel.2010.07.011

10.1038/nature07086

10.1016/j.devcel.2010.10.022

10.1016/j.cardiores.2007.08.003

10.1007/BF00223261

10.1161/CIRCULATIONAHA.107.687947

10.2144/05391RV01

10.1038/nprot.2008.73

10.2741/e541

10.1161/CIRCRESAHA.108.178434

10.1161/ATVBAHA.114.304345

10.1182/blood-2011-08-373886

10.1182/blood-2012-04-423004

10.1038/cr.2008.302

10.1016/j.tem.2014.05.003

10.1152/ajpregu.00534.2009

10.1038/nrcardio.2015.156

10.7150/ijbs.8.195

10.1242/jcs.122333

10.1016/j.ceb.2012.12.005

10.1161/CIRCULATIONAHA.110.964684

10.1007/s10456-015-9474-5

10.1161/CIRCRESAHA.114.304747

10.1038/nm.3487

10.1101/cshperspect.a006627